Generic Zantac Makers Can File Some Cost Information Under Seal

Generic antacid makers that were dismissed from federal multidistrict litigation alleging the drugs caused cancer and now plan to ask that costs be imposed on the plaintiffs, may file certain supporting materials under seal, the MDL court said.

The court in July dismissed Apotex Inc. and other makers of generic versions of Zantac, which the companies say makes them prevailing parties and raises the presumption that they are entitled to an award of litigation costs.

Apotex and other companies sought to file under seal parts of invoices related to electronically stored information charges from their discovery support vendors and evidence ...